Literature DB >> 1586056

Nebulizer function during mechanical ventilation.

T G O'Riordan1, M J Greco, R J Perry, G C Smaldone.   

Abstract

In the setting of mechanical ventilation, recent studies have cast doubt on the ability of nebulizer systems to deliver adequate amounts of medication. We therefore studied ventilator-related and nebulizer-related factors that could potentially affect the amount of aerosol inhaled by an intubated subject. Utilizing two separate protocols, we used a bench model of a ventilator circuit, radiolabeled (technetium pertechnetate, 99mTc) saline droplets and a filter technique to measure the percentage of radioaerosol delivered. First, we compared four commercially available jet nebulizers and found that there were significant differences in rate of aerosol production between systems, ranging from 3 to 37%. Delivered aerosol was measured at different ventilator settings, and it was found that the duty cycle can potentially influence output by sevenfold. Some nebulizers were also sensitive to changes in the initial volume of solution placed in the nebulizer. The inclusion of a humidification device significantly reduced output by a mean of 41 +/- 3.5%, but it did not affect particle distribution. Endotracheal tube diameter was not an important variable. Then, with the effects of the above variables established, a separate series of experiments was performed to test whether the use of different radiolabeling compounds can confound the measurement of inhaled drugs. Two nebulizers (AeroTech II and Twin Jet) and pentamidine as the test drug were studied with fixed ventilator settings, treatment time, endotracheal tube size, and volume fill. No humidification was used. The nebulizer solution was labeled with 99mTc, which was bound to either human serum albumin (HSA) or sulfur colloid (SC).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1586056     DOI: 10.1164/ajrccm/145.5.1117

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  20 in total

1.  Maximizing aerosol delivery during mechanical ventilation: go with the flow and go slow.

Authors:  Rajiv Dhand
Journal:  Intensive Care Med       Date:  2003-07       Impact factor: 17.440

2.  In vitro assessment of drug delivery through an endotracheal tube using a dry powder inhaler delivery system.

Authors:  M L Everard; S G Devadason; P N Le Souëf
Journal:  Thorax       Date:  1996-01       Impact factor: 9.139

Review 3.  Aerosolised antibacterials for the prevention and treatment of hospital-acquired pneumonia.

Authors:  G Christopher Wood; Joseph M Swanson
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 4.  Nebuliser therapy in childhood.

Authors:  P W Barry; C O'Callaghan
Journal:  Thorax       Date:  1997-04       Impact factor: 9.139

5.  The use of condensational growth methods for efficient drug delivery to the lungs during noninvasive ventilation high flow therapy.

Authors:  Laleh Golshahi; Geng Tian; Mandana Azimi; Yoen-Ju Son; Ross Walenga; P Worth Longest; Michael Hindle
Journal:  Pharm Res       Date:  2013-06-26       Impact factor: 4.200

Review 6.  Pharmacologic treatment of the adult hospitalized asthma patient.

Authors:  M L Kreutzer; S Louie
Journal:  Clin Rev Allergy Immunol       Date:  2001-06       Impact factor: 8.667

Review 7.  Inhaled Antibiotics for Gram-Negative Respiratory Infections.

Authors:  Eric Wenzler; Dustin R Fraidenburg; Tonya Scardina; Larry H Danziger
Journal:  Clin Microbiol Rev       Date:  2016-07       Impact factor: 26.132

8.  Pulmonary deposition of a nebulised aerosol during mechanical ventilation.

Authors:  S H Thomas; M J O'Doherty; H M Fidler; C J Page; D F Treacher; T O Nunan
Journal:  Thorax       Date:  1993-02       Impact factor: 9.139

9.  Prostacyclin aerosol in an infant with pulmonary hypertension.

Authors:  B Santak; M Schreiber; P Kuen; D Lang; P Radermacher
Journal:  Eur J Pediatr       Date:  1995-03       Impact factor: 3.183

10.  Aerosol therapy during mechanical ventilation: an international survey.

Authors:  Stephan Ehrmann; Ferran Roche-Campo; Giuseppe Francesco Sferrazza Papa; Daniel Isabey; Laurent Brochard; Gabriela Apiou-Sbirlea
Journal:  Intensive Care Med       Date:  2013-03-23       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.